Cellular immune responses in acute leukaemia patients with severe chemotherapy-induced leucopenia; characterization of the cytokine repertoire of clonogenic T cells

Cancer Immunology Immunotherapy

Volumn 46, Issue 4, 1998, Pages 221-228

  Bruserud, Øystein ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Acute leukaemia; Cytokine responses; Cytotoxic drugs; Leucopenia; T lymphocytes

Indexed keywords

ANTINEOPLASTIC AGENT; CYTARABINE; DAUNORUBICIN;

ACUTE LEUKEMIA; ADULT; AGED; ARTICLE; BLAST CELL; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CYTOKINE RELEASE; FEMALE; HELPER CELL; HUMAN; IMMUNE RESPONSE; LEUKOPENIA; LYMPHOCYTE ACTIVATION; MALE; MOLECULAR CLONING; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CLONE CELLS; CYTARABINE; CYTOKINES; DAUNORUBICIN; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-10; INTERLEUKIN-2; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOID; LEUKOPENIA; LYMPHOPENIA; MALE; MIDDLE AGED; PHYTOHEMAGGLUTININS; STIMULATION, CHEMICAL;

EID: 0031778868     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050481     Document Type: Article

References (33)

1. Anaissie E (1992) Opportunistic mycosis in the immunocompromised host: experience at a cancer centre and review. Clin Infect Dis 14 [Suppl 1]: S43
2. Bennett JM, Catovsky D, Daniel M-T, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1976) Proposals tor the classification of the acute leukaemias Br J Haematol 33: 451
3. Bishop JF, Matthews JP, Young GA, Szer J, Gillett A, Joshua D, Bradstock K, Enno A, Wolf MM, Fox R, Cobcroft R, Herrmann R, Weyden M van der, Lowenthal RM, Page F, Carson OM, Juneja S (1996) A randomized study of high-dose cytarabine in induction in acute myeloid leukemia. Blood 87: 1710
4. Bradbury D, Zhu Y-M, Russell N (1994) Regulation of Bcl-2 expression and apoptosis in acute myeloblastic leukaemia cells by granulocyte-macrophage colony-stimulating factor. Leukemia 8: 786
5. Bruserud Ø (1996) Effects of interleukin 13 on cytokine secretion by acute myelogenous leukemia blasts. Leukemia 10: 1497
6. Bruserud Ø, Pawelec G (1996) Human T lymphocyte activation in the presence of acute myelogenous leukaemia blasts: studies of normal polyclonal T cells and T lymphocyte clones derived early after allogeneic bone marrow transplantation. Cancer Immunol Immunother 42: 133
7. + T cell clones derived early after allogeneic bone marrow transplantation; studies in patients with chronic myelogenous leukaemia. Eur J Haematol 48: 221
8. + T cell clones derived early after allogeneic bone marrow transplantation. Scand J Immunol 38: 65
9. Bruserud Ø, Gjertsen BT, Brustugun OT, Bassoe C-F, Nesthus I, Akselsen PE, Bühring H-J, Pawelec G (1995) Effects of interleukin 10 on blast cells derived from patients with acute myelogenous leukemia. Leukemia 9: 1910
10. Bruserud Ø, Nesthus I, Bühring H-J, Pawelec G (1995) Cytokine modulation of interleukin I and tumour necrosis factor-α secretion from acute myelogenous leukaemia blast cells in vitro. Leukemia Res 19: 15
11. Bruserud Ø, Halstensen A, Peen E, Solberg CO (1996) Serum concentrations of cytokines and soluble adhesion molecules in patients with acute leukaemia. Leuk Lymphoma 23: 423
12. Bruserud Ø, Ulvestad E, Halstensen A, Berentsen S, Berheim J, Nesthus I (1997) Interleukin 4 responses in acute leukaemia patients with severe chemotherapy-induced leucopenia. Eur J Haematol 59: 269
13. Cardoso AA, Schultze JL, Boussioutis VA, Freeman GJ, Seamon MJ, Laszlo S, Billet A, Sallan SE, Gribben JG, Nadler LM (1996) Pre-B acute lymphoblastic leukemia cells may induce T cell anergy to alloantigen. Blood 88: 41
14. Conrad Liles V, Voorhis WC van (1995) Review: nomenclature and biologic significance of cytokines involved in inflammation and the host immune response. J Infect Dis 172: 1573
15. Fidel PL Jr, Sobel JD (1994) The role of cell-mediated immunity in candidiasis. Trends Microbiol 2: 202
16. Hamann W, Bruserud Ø, Patel S, Schmidt H, Ehninger G, Pawelec G (1991) Cytotoxic and proliferative functions of T lymphocyte clones derived early after allogeneic bone marrow transplantation. Bone Marrow Transplant 8: 113
17. Koll BS, Brown AE (1993) The changing epidemiology of infections at cancer hospitals. Clin Infect Dis 17 [Suppl 2]: S322
18. Larson RA, Dodge RK, Burns CP, Lee HJ, Stone RM, Schulman P, Duggan D, Davey FR, Sobol RE, Frankel SR, Hooberman AL, Westbrook CA, Arthur DC, George SL, Bloomfield CD, Schiffer CA (1995) A five-drug remission induction regimen with intensive consolidation for adults with acute lymphohlastic leukemia. Blood 85: 2025
19. Lefkovits I, Waldman H (1984) Limiting dilution analysis of the cells of the immune system. I. The clonal basis of the immune response. Immunol Today 5: 265
20. Meer JWM van der (1994) Defects in host defense mechanisms. In: Rubin RH, Young LS (eds) Clinical approach to infections in the immunocompromised host, 3rd edn. Plenum, New York, p 33
21. Meyer RJ, Davis RB, Schiffer CA, Berg DT, Powell BL, Schulman P, Omura GA, Moore JO, McIntyre OR, Frei III E (1994) Intensive postremission therapy in adults with acute myeloid leukemia. N Engl J Med 331: 896
22. Openshaw P, Murphys EE, Hosken NA, Maino V, Davis K, Murphy K, O'Garra A (1995) Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper I and T helper 2 populations. J Exp Med 182: 1357
23. Ostermann H, Rothenburger M, Mesters RM, van de Loo J, Kienast J (1994) Cytokine response to infection in patients with acute myelogenous leukaemia following chemotherapy. Br J Haematol 88: 332
24. Pawelec G (1994) Immune surveillance in leukemia: a rationale for immunotherapy? Hematol Rev 8: 123
25. Romagnani S (1991) Human Th1 and Th2 subsets: doubt no more. Immunol Today 12: 256
26. Romani L, Howard DH (1995) Mechanisms of resistance to fungal infections. Curr Opin Immunol 7: 517-523
27. Rubio M, Palau L, Romero Vivas J, Potro E del, Diaz-Mediavilla J, Alvarez A, Martinez R, Picazo JJ (1994) Predominance of gram-positive microorganisms as a cause of septicemia in patients with hematological malignancies. Infect Control Hosp Epidemiol 15: 101
28. Sachs L, Lotem J (1993) Control of programmed cell death in normal and leukemic cells: new implications for therapy. Blood 82: 15
29. Sher A (1992) Regulation of immunity to parasites by T cells and T cell derived cytokines. Annu Rev Immunol 10: 385
30. Tony HP, Shen B-J, Reusen P, Sebald W (1994) Designs of human interleukin 4 antagonists inhibiting interleukin 4-dependent and interleukin 13-dependent responses in T and B cells with high efficiency. Eur J Biochem 225: 659
31. Velardi A, Varese P, Terenzi A, Dembech C, Albi N, Grossi CE, Moretta L, Martelli MF, Grignani F, Mingari MC (1989) Lymphokine production by T cell clones after human bone marrow transplantation. Blood 74: 1665
32. Young LS (1994) Management of infections in leukemia and lymphoma.In: Rubin RH, Young LS (eds) Clinical approach to infection in the compromised host, 3rd end. Plenum, New York, p 551
33. Zurawski SM, Vega F, Huyghe B, Zurawski G (1993) Receptors for interleukin 13 and interleukin 4 are complex and share a novel component that functions in signal transduction. EMBO J 12: 2663